Back to top Open menu arrow
Reprints

The Journal of
Clinical Psychiatry
Free access

The Journal of Clinical Psychiatry

Insights August 24, 2021

AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adult ADHD

AR19, a manipulation-resistant formulation of amphetamine sulfate, was created to address the problem of non-oral use of stimulant medications (eg, smoking, injecting). In this video, Dr Faraone highlights the findings and implications of a recent randomized controlled trial of AR19 in adult ADHD.

Read the full article

Also from JCP

Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time Early-Life Injuries and Later ADHD Rescue Therapy for Epilepsy Seizure Clusters

From the Editors

Live Webinar · Oct 12 GLP-1 Receptor Agonists for Long-Term Kidney Protection Dr. Balwinder Singh (Mayo Clinic) and Dr. Raman Baweja (Penn State) review emerging evidence on whether GLP-1 RAs may protect kidney function in adults with bipolar disorder and mild-to-moderate CKD. Free, Monday, October 12, 2:00 PM ET. Register now

About the Authors

The Journal of Clinical Psychiatry September 2026 cover featuring key articles on depression therapy

Vol 87 • 2026 • Number 3

Read the Current Issue

Original Research

Inhaled Mebufotenin (GH001) for Adult Patients with Postpartum Depression

Original Research

US Mortality Involving Obesity and Psychiatric Disorders

Academic Highlights

Treatment-Resistant Depression as a Dynamic Continuum: A Consensus Panel Report

Original Research

Effects of Brexpiprazole on Functioning in Patients with Schizophrenia Who Have Hostility and Agitation Symptoms

Original Research

Exposure-Based Video Therapy for OCD and PTSD

Original Research

Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress
View current Issue

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe